ADPT · Adaptive Biotechnologies Corp
United States · RS rating 80 · As of 2026-11-03
| Price | 25.80 USD |
|---|---|
| 1-day change | +3.0% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 29 / 76 / 85 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 48 / 66 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -250.0% |
| Sales growth Q/Q | -23.7% |
| Distance from 52-week high | +13.5% |
| Market cap (USD) | $2.1B |